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ABSTRACT
Objectives: To evaluate the current evidence for the
efficacy of corticosteroid injection and non-
electrotherapeutic physiotherapy compared with control
for treating lateral epicondylitis.
Design: Systematic review.
Participants: We searched five databases in
September 2012 for randomised controlled studies
with a minimum quality rating. Of the 640 studies
retrieved, 11 were included, representing 1161 patients
of both sexes and all ages.
Interventions: Corticosteroid injection and non-
electrotherapeutic physiotherapy.
Outcome measures: Relative risk (RR) or
standardised mean difference (SMD) for overall
improvement, pain and grip strength at 4–12, 26 and
52 weeks of follow-up.
Results: Corticosteroid injection gave a short-term
reduction in pain versus no intervention or non-
steroidal anti-inflammatory drugs (SMD −1.43, 95% CI
−1.64 to −1.23). At intermediate follow-up, we found
an increase in pain (SMD 0.32, 95% CI 0.13 to 0.51),
reduction in grip strength (SMD −0.48, 95% CI −0.73
to −0.24) and negative effect on the overall
improvement effect (RR 0.66 (0.53 to 0.81)). For
corticosteroid injection versus lidocaine injection, the
evidence was conflicting. At long-term follow-up, there
was no difference on overall improvement and grip
strength, with conflicting evidence for pain.
Manipulation and exercise versus no intervention
showed beneficial effect at short-term follow-up
(overall improvement RR 2.75, 95% CI 1.30 to 5.82),
but no significant difference at intermediate or long-
term follow-up. We found moderate evidence for short-
term and long-term effects of eccentric exercise and
stretching versus no intervention. For exercise versus
no intervention and eccentric or concentric exercise
and stretching versus stretching alone, we found
moderate evidence of no short-term effect.
Conclusions: Corticosteroid injections have a short-
term beneficial effect on lateral epicondylitis, but a
negative effect in the intermediate term. Evidence on
the long-term effect is conflicting. Manipulation and
exercise and exercise and stretching have a short-term
effect, with the latter also having a long-term effect.
INTRODUCTION
Lateral epicondylitis of the elbow is a fre-
quently encountered complaint in general
practice with an incidence of 4–7/1000/
year.1–3 It is characterised by pain and tender-
ness over the lateral humeral epicondyle and
pain on resisted dorsiﬂexion and radial devi-
ation of the wrist. It is usually a self-limiting
condition, often resolving in 6–12 months
regardless of treatment, but complaints may
last up to 2 years or longer.4 Owing to consid-
erable pain and discomfort, many patients
need time off from work.
Most authors attribute the condition to a
lesion in the short radial extensor muscle.1 5
A recent study has found evidence of
reduced hyperaemia measured with spectral
and colour Doppler in lateral epicondylitis
treated with corticosteroid injection, suggest-
ing the evidence of an inﬂammatory compo-
nent.6 Others, ﬁnding little evidence of
inﬂammation, have proposed the term
‘lateral epicondylalgia’ for the condition.7
Most patients with lateral epicondylitis are
treated in general practice, and although a
ARTICLE SUMMARY
Strengths and limitations of this study
▪ We found few good quality studies on non-electro-
therapeutic physiotherapy. A meta-analysis was
possible for one of the investigated treatments.
▪ The conclusions on the efficacy of corticosteroid
injections are based on eight studies, and are
strongest for short-term and intermediate-term
results.
▪ Owing to large heterogeneity between studies,
only some outcomes on corticosteroid injections
were possible to pool.
▪ We included only studies with a control-group
with no treatment and used an established quality
rating scale, which strengthens the review.
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large number of treatments are in use, there is no consen-
sus on which treatments are most effective. The Cochrane
Library has reviewed several treatments. For topical non-
steroidal anti-inﬂammatory drugs (NSAIDs) and NSAIDs
taken orally, the conclusion is that both may have a short-
term effect.8 For extracorporeal shockwave therapy, a
review of nine studies including 1000 patients found this
treatment to have no effect.9 For acupuncture,10 deep fric-
tion massage,11 orthosis12 and surgery,13 the reviews were
inconclusive due to few published studies.
Four review articles have been published on the effect
of corticosteroid injections.14–17 They found a short-term
effect of corticosteroid injection, but no proven long-
term effect, and one review found evidence of a negative
long-term effect.15 However, some of the reviews
included non-controlled studies14 16 and non-
randomised studies.16 In one review,15 4 of the 12
included studies had no control group and one was a
small pilot study with a short follow-up. Based on this,
we ﬁnd evidence in published reviews on the long-term
effect of corticosteroid injections to be conﬂicting.
Five reviews of physiotherapeutic interventions show
that there are few published studies on the effect of
non-electrotherapeutic treatment, and many have meth-
odological weaknesses.16 18–21 Bisset et al18 found evi-
dence that manipulation and exercise had a short-term
effect. Four other reviews16 19–21 found short-term effects
of mobilisation, manipulation and exercise. Three of
these reviews included non-randomised or non-
controlled studies.16 19 21 Most previous systematic reviews
have included electrotherapeutic physiotherapy such as
ultrasound and extracorporeal shockwave.14 16 20 21
Since there is no established, well-documented treat-
ment to which new treatments can be compared, the
use of a control group is important. The natural course
of the condition, where most patients eventually recover
regardless of the intervention, makes this even more
necessary. In a comparison of two different treatments,
any effect found may only reﬂect this natural course of
recovery unless the treatments prove better than a
control group with no treatment.
It has been shown that systematic reviews which
include studies with low scores on internal validity may
overestimate effect sizes, thus introducing a potential
bias to the review.22 There may also be a problem using
rating scales with heterogeneous criteria, including that
is, criteria related to external validity, interpretation or
ethical issues.22 23
To address these issues, a new systematic review on
non-electrotherapeutic physiotherapy and corticosteroid
injection seemed warranted. We wanted to include only
randomised studies with a control group with no treat-
ment or studies in which the groups only differed in
regard to the investigated treatment. An established
quality rating scale would be used. We also wanted to
review the most current evidence on the efﬁcacy of cor-
ticosteroid injections, since previous reviews have differ-
ing conclusions on the long-term effect.
Objective
The aim of this review was to assess the current evidence
for the efﬁcacy of corticosteroid injections and
non-electrotherapeutical physiotherapy compared with
control in patients with tennis elbow.
METHODS
We followed the recommendations of the Cochrane
Collaboration24 and the PRISMA Group25 in the search
and report of this systematic review.
Study selection
We used the following inclusion criteria.
Study type
Randomised controlled trials assessing treatments for
lateral epicondylitis or tennis elbow were eligible for
inclusion. The studies had to have at least one treatment
group and one control group. We deﬁned a control
group as a group receiving no treatment (a wait-and-see
approach), common treatments with expected or known
moderate effect (advice, rest, NSAIDs, painkillers) or
the same treatment as the experimental group with the
exception of the investigated treatment.
Participants
All age groups with a clinical diagnosis of lateral epicon-
dylitis were included without restriction on the gender.
Treatments
We searched for studies investigating or comparing the
efﬁcacy of one of the following treatments: corticoster-
oid injection, non-electrotherapeutic physiotherapy
including stretching, mobilisation, manipulation,
massage, exercise or home training. Studies on the
splinting, ultrasound, shock wave and other electrothera-
peutic modalities were excluded.
Outcome measures and follow-up
At least one validated, patient-centred outcome was
necessary. This could include outcomes important to
the patient, such as pain, range of movement, grip
strength, work status and relevant functional question-
naires. We included only studies carried out in a clinical
setting with at least a 4-week follow-up of the treatment
effect.
Study quality assessment
We used the 11-item Physiotherapy Evidence Database
(PEDro) scale to assess the quality of the studies
included in the review. This rating system closely resem-
bles the Cochrane Collaboration Scoring system24 and is
based on the Delphi list, developed for quality assess-
ment of randomised controlled trials (RCTs) by
Verhagen et al26 It has been used in several previously
published reviews.15 18 19 The PEDro scale assesses the
internal and external validity of a study by addressing
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the issues of eligibility criteria, randomisation, allocation,
blinding, statistics and data reporting. The reliability of
this scale has been conﬁrmed by Maher et al.27. The
maximum score is 10, since item number 1 on the scale
(speciﬁed eligibility criteria) is not counted.
A minimum score of 5t of 10 points (50%) was chosen
to be necessary for inclusion in the review, as inclusion
of lower quality studies in a systematic review may over-
estimate the treatment effect of interventions.28 Ten
studies were independently assessed by two researchers
(MO and ØH)29–38 and three studies were rated by both
researchers together.39–41 The ﬁnal decision on the
PEDro score was reached by consensus.
Search methods for identification of studies
Electronic searches
From October 2009 to January 2010, we searched the
following databases for publications: MEDLINE (Ovid
and PubMed), EVSCO/CINAHL, EMBASE, Allied and
Complimentary Medicine, PEDro and the Cochrane
RCT register. The searches within each database were
carried out without restrictions on dates or languages.
We used free text, not MESH terms, in these searches,
and the key terms used were ‘tennis elbow’, ‘lateral epi-
condylitis’, epicondylalgia, elbow, randomised, injection,
corticosteroid and physiotherapy. The Boolean operator
AND was used to link diagnostic terms and treatment
where applicable. An additional search was carried out
in September 2012 to identify any recently published
studies.
Searching other resources
Further search was carried out in the reference list of
articles initially considered for review.
Selection of studies
The searches resulted in a number of studies potentially
eligible for inclusion. Titles and abstracts were then read
by two researchers independently (MO and ØH) and
potential studies were selected based on the inclusion
criteria. The ﬁnal decision on inclusion was made by
consensus from a reading of the full-text documents.
Data extraction and statistical analysis
The included studies were read in full text and assessed
by two independent researchers (MO and ØH). One
article, published in Italian, was translated by a profes-
sional bureau.41 A standardised set of data was extracted
from each selected study and recorded using standar-
dised forms. We calculated statistics using the statistical
computing language R (http://www.r-project.org, The
R Foundation for Statistical Computing, Vienna,
Austria). We reported the results of the outcome mea-
sures for three different timings of follow-up, deﬁned as
short term (4–12 weeks after randomisation), intermedi-
ate term (6 months after randomisation) and long term
(more than 6 months after randomisation). For dichot-
omous data, we calculated relative risk (RR) and 95% CI
with the R-project library ‘epi.R’, for continuous data,
the standardised mean difference (SMD) and 95% CI
with the R-project library ‘compute.es’. We pooled esti-
mates when we found sufﬁcient clinical and statistical
homogeneity between trials using the I2 statistic, deﬁned
as I2 less than 65%.42
Some studies did not report the mean, SD or number
of samples, which were necessary to calculate SMD.
Additional calculations were then required. For
Coombes,38 the median and the IQR were given. We set
the median as the mean value and the SD was given by
IQR/1.35 under the assumption of normal distribution.
For Newcomer,33 SD was calculated by the t-statistics
obtained by the p value and degrees of freedom. For
Price et al,34 the t-statistics were obtained by the degrees
of freedom and 95% probability. SD was estimated by
the t-statistics, the mean value and the upper/lower CIs.
For overall improvement, an RR larger than 1
favoured treatment and was statistically signiﬁcant if the
CI excluded 1. We deﬁned the effect as large for values
larger than 2 or less than 0.5, medium between 0.5 and
0.8 and between 1.25 and 2 and small for values
between 0.8 and 1.0 and between 1.0 and 1.25.
For continuous data, a positive or negative SMD
favoured treatment depending on the outcome mea-
sures, that is, for pain, a negative SMD favoured treat-
ment and for grip strength a positive SMD favoured
treatment. SMD was statistically signiﬁcant if the CI
excluded 0. We deﬁned the effect as large for SMD
more than 0.8, medium between 0.5 and 0.8 and small
for values less than 0.5. For outcomes that could not be
pooled, we graded the strength of the scientiﬁc evidence
as strong (consistent ﬁndings in several high quality ran-
domised controlled studies), moderate (one high quality
randomised controlled study), conﬂicting (inconsistent
ﬁnding between many studies) or no evidence.43
Inter-rater reliability
The inter-rater reliability for the individual PEDro scores
was assessed by calculating the intraclass correlation
coefﬁcient.44 The R-project library ‘psych’ was used for
this calculation. A substantial inter-rater reliability was
found (intraclass correlation coefﬁcient 0.69 (0.15–
0.91), p<0.01).
RESULTS
The search retrieved an initial 839 hits, representing 640
individual articles. The further selection process is out-
lined in ﬁgure 1. Six hundred and twenty-three articles
were excluded based on the title and abstract in a pre-
liminary review. Seventeen articles29–37 39 41 45–50 were
then assessed using the full-text documents. Three were
found not to be RCTs,45–47 two had a PEDro quality
rating below 50% (table 2)37 39 and three had a
follow-up shorter than 4 weeks.48–50 The additional
search carried out in September 2012 retrieved two pos-
sible studies,40 51 one of which was excluded for not
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having a control group.51 A recently published study was
also assessed38 and a total of 11 studies were included in
the ﬁnal review.29–36 38 40 41
Included studies
The characteristics and details of each study are given in
table 1. The included studies represented a total popula-
tion of 1161 patients. Several studies had more than one
treatment group, so the 11 included studies investigated
15 treatment groups relevant for this review. For the stat-
istical analysis, one study, which used two different corti-
costeroids, was treated as two studies.34
The mean age of patients varied from 41 to 51 years
and the female percentages varied from 35 to 63. There
were large differences in the duration of complaints at
baseline between studies. Most had a duration of several
weeks to months and only one stated a short duration.33
Eight studies had control groups with no active treat-
ment,29–31 34–36 38 40 for example, a wait-and-see group
or NSAIDs. Two of these used lidocaine as a placebo
injection.31 34 In the three other studies, the control and
treatment groups both received similar active treatments,
with the intervention group additionally receiving the
treatment to be investigated.32 33 41
Eight studies investigated corticosteroid injections,
representing 925 patients.29–31 33–36 38 Five different cor-
ticosteroids were used, with different dosages and injec-
tion techniques. The control groups received no active
treatment in seven of the eight studies, whereas in one
study the control and the treatment groups received
additional exercise treatment.33 Seven of the studies had
a long-time follow-up of 24 weeks or more.29–31 33–35 38
There were few studies covering non-electrotherapeutic
physiotherapy. We found ﬁve studies which could be
included, representing 600 patients.29 32 38 40 41 The treat-
ment modalities investigated were manipulation and
exercise,29 38 concentric or eccentric exercises,32 and
exercise40 and eccentric exercises with stretching.41
Three studies had a control group with no active treat-
ment,29 38 40 whereas the other two had control groups
that received stretching and orthosis, respectively. Three
studies29 38 41 had a follow-up of 24 weeks or more.
The most frequently used outcome measures
were assessment of pain and grip strength. Six
studies measured pain-free grip strength with hand-held
dynamometers.29–33 35 Eight studies used a number of
different questionnaires covering pain, function and dis-
ability.29–33 35 38 40 Nine studies assessed pain on a visual
analogue scale or Likert scale,29–34 36 38 40 and six
studies rated the patient’s assessment of improvement
on graded scales.29 30 35 36 38 41
Risk of bias in included studies
We addressed the issues of the quality of the included
studies and completeness of reported data by rating
them with the PEDro scale (table 2). Most studies used a
computerised randomisation schedule, and 7 of the 11
studies used concealed allocation.29–31 35 38 40 41
Baseline comparison was carried out in all studies, the
dropout rate was below 15% in 10 studies29 30 32–
36 38 40 41 and intention-to-treat analysis was stated in all
studies. There was between-group analysis of at least one
outcome measure in all the studies, and both point mea-
sures and variations of outcome measures were reported
in all studies.
The use of blinding was more diverse among the
studies. Blinding the patient for treatment is difﬁcult for
physiotherapeutic treatments, but the use of blinded
assessors reduces the risk of bias. None of the studies on
physiotherapy in our review had blinded patients or
therapists, but two used blinded assessors.29 38 This
might give biased results in the studies covering phy-
siotherapeutic treatments.
For the eight studies on corticosteroid injection,
the number using blinding was larger. There was
blinding of patients in four studies,31 33 34 38 of the
treating doctor in two studies31 33 and of assessors in six
studies.29–31 34 35 38
In several studies, the control group received some form
of treatment (similar to the treatment group).32–34 36 41 In
these studies, synergistic effects between the treatments
cannot be ruled out. This makes the results more difﬁcult
Figure 1 Outline of the selection process.
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Table 1 Demographics, treatments and outcome measures in the eleven included studies
Study and
year setting
and sample
size
Women
(percentages)
Age (mean if not
otherwise stated)
Duration of
discomforts
(weeks) Treatment groups Control group
Outcome measures
(excerpts)
Follow-up
(weeks)
Bisset et al
2006
Outpatient clinic
n=198
35 47.6 (SD 7.8) 22 (median)
(IQR 12–42)
(1) 10 mg Triamcinolone and
1 mL lidocaine against the most
painful point repeated after
2 weeks
(2) Elbow manipulation
(manipulation with movement)
and exercise
8 sessions of 30 min duration
during a 6 week period and
home exercise
Information,
wait-and-see
Improvement on
6-point Likert-scale
PFGS assessed
severity on VAS
Pain on VAS
Pain-free function
questionnaire
52
Coombes et al
2013
Community
setting n=165
38 49.7 (SD 8.1) 16 (median)
(IQR 10–26)
(1) One injection of 1 mL
triamcinolone 10 mL/mL and
1 mL lignocaine 1% against site
of greatest palpable tenderness
at the common extensor origin
(2) Elbow manipulation
(manipulation with movement)
and exercise
8 sessions of 30 min duration
during a 8 week period and
home exercise
(3) One injection of
triamcinolone followed by 8
sessions of elbow manipulation
and exercise, home exercise for
8 weeks (not considered in this
review)
Placebo injection
0.5 mL 0.9% isotonic
saline
Improvement on
6-point Likert-scale
1 year recurrence
Pain on VAS
PRTEE questionnaire
EuroQol-EQ-5D
quality-of-life score
52
Hay et al 1999
General
practice n=164
Group 1:41
(Group 2:53)
Control:48
Age ≥45:
(percentages)
Group 1:70
(Group 2:68)
Control:38
9 (mean)
Percentage with
pain >3 months:
Group 1:36
(Group 2:25)
Control:31
(1) One injection of
methylprednisolone 20 mg and
0.5 mL 1% lignocaine towards
tender spot
(2) Naproxen orally 500 mg
twice daily for 2 weeks (not
considered in this review)
Placebo tablets Improvement on
5-point Likert-scale
Pain on 10-point
Likert-scale
Function on 10-point
Likert-scale
Main discomfort on
10-point Likert-scale
Disability
questionnaire
PFGS
52
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Table 1 Continued
Study and
year setting
and sample
size
Women
(percentages)
Age (mean if not
otherwise stated)
Duration of
discomforts
(weeks) Treatment groups Control group
Outcome measures
(excerpts)
Follow-up
(weeks)
Price et al 1991
Outpatient clinic
n=88
Group 1:48
Group 2:43
Control:38
Group 1:47
Group 2:47
Control:46
(Median)
Group 1:20 (6–
150)
Group 2:36 (6–
154)
Control:16 (6–150)
(Median and
range)
(1) Hydrocortisone 25 mg and
1% lidocaine against tender
point (2 mL fluid) (55% received
2 injections)
(2) Triamcinolone 10 mg and
1% lidocaine (30% received
two injections)
2 mL 1% lidocaine
against tender point
Pain on VAS
Tenderness score
Pain-weighted grip
strength
24
Smidt et al
2002
General
practice n=185
Group 1:55
(Group 2:44)
Control: 53
Group 1: 47
(Group 2:48)
Control: 46
(Median)
Group 1:11 (8–16)
(Group 2:11 (8–
21))
Control:11 (8–21)
(Median and IQR)
(1) 10 mg triamcinolone and
1 mL lidocain against all tender
points up to three injections
(2) One group received
physiotherapy with ultrasound
(not considered in this review)
Wait-and-see (some
were prescribed
naproxen orally
1000 mg daily)
Improvement on
6-point Likert scale
Severity of discomfort
on scale
Questionnaires
PFGS
Maximum grip
strength (MGS)
Pressure-pain
measurements
Satisfaction with
treatment
52
Toker et al
2008
Outpatient clinic
n=21
43 45 (range 19–72) Not stated One injection of 1 mL
metylprednisolon and 1 mL
prilocain with oral diklofenac
three tablets (dose not stated)
and etofenamate topically
Oral diklofenac three
tablets (dose not
stated) and
etofenamate topically
Perceived absence of
pain
Absence of pain on
palpation over lateral
epicondyle and on
isometric dorsiflection
of wrist pain score
4
Lindenhovius
et al 2008
Outpatient clinic
n=64
Treatment: 63
Control: 60
Treatment: 50±8
Control: 51±10
Treatment: 12±4
(2–20)
Control: 8±4 (1–20)
4 mg dexamethasone and
10 mg lidocaine (2 mL fluid)
against the most tender spot,
fanning of the needle. One
injection—but 6 of 64 got 2
injections
10 mg lidocain, 2 mL
fluid total
DASH questionnaire*
Pain on VAS
Grip strength
26
Newcomer et al
2001
Outpatient clinic
n=39
51 Treatment:
46.0± 7.0
Control: 44.6±7.6
Treatment: 3.2
(mean) SD 0.8
Control: 3.4 (mean)
SD 0.9
One injection of 5 mL 4:1
0.25% bupivacaine and 6 mg/
mL β-methasone against tender
point. Home exercises
consisting of ice massage, wrist
stretching and progressive
Placeboinjection of
5 mL bupivacaine
Home exercises
consisting of ice
massage, wrist
stretching and
progressive eccentric
Pain on VAS
Functional pain
questionnaire (PFGS
at 4 and 8 weeks)
26
Continued
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Table 1 Continued
Study and
year setting
and sample
size
Women
(percentages)
Age (mean if not
otherwise stated)
Duration of
discomforts
(weeks) Treatment groups Control group
Outcome measures
(excerpts)
Follow-up
(weeks)
eccentric and concentric
exercises
and concentric
exercises
M-Silvestrini
et al 2005
Outpatient clinic
n=94
47 45.5±7.7 More than 12 (1) Concentric strengthening
3×10 repetitions once daily and
wrist stretching twice daily for
6 weeks
(2) Eccentric strengthening
3×10 repetitions once daily and
wrist stretching twice daily for
6 weeks
Wrist stretching twice
daily for 6 weeks
PFGS
Pain on VAS
PRFEQ questionnaire
Patient’s log of training
DASH questionnaire*
6
Peterson et al
2011
General
practice n=81
42 48 Treatment: 107
Control: 96
Three-month daily exercise
regime performed at home with
progressively increasing load
on the extensor muscles
Information,
wait-and-see
Pain on VAS during
contraction and during
elongation of forearm
muscles
Muscle strength with
hand-held
dynamometer
DASH questionnaire
12
Selvanetti et al
2003
Setting not
stated n=62
Treatment: 45
Control: 48
Treatment: 41.3
Control: 40.5
Treatment: 28 (8–
40)
Control: 29 (12–44)
4 weeks home-exercise after
instruction from physiotherapist
consisting of stretching and
eccentric exercise
Counselling and use of elbow
support
Sham ultrasound 20
sessions
Counseling and use of
elbow support
Ko scoring system
(includes clench test,
Thomsen test and
pain)
Verhaar scoring
system on global
improvement
Subjective
improvement VAS
scale (0–100)
44 (24–56)
*DASH questionnaire is an upper extremity specific health status measure.
DASH,Disability of the Arm, Shoulder and Hand; PFGS, Pain-Free Grip Strength;PRFEQ, Patient-rated Forearm Evaluation Questionnaire; PRTEE questionnaire, Patient-Rated Tennis Elbow
Score, VAS, Visual Analogue Scale.
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Table 2 Quality rating of studies by assessing internal and external validity with the PEDro scale
Study
PEDro criterion Bisset Coombes Hay Price Smidt Toker Lindenhovius Newcomer M-Silvestrini Peterson Selvanetti Kochar Tonks
1 Eligibility criteria were
specified
1 1 1 1 1 1 1 1 1 1 1 1 1
2 Participants were
randomly allocated to
groups
1 1 1 1 1 1 1 1 1 1 1 1 1
3 Allocation was
concealed
1 1 1 0 1 0 1 0 0 1 1 0 1
4 The groups were similar
at baseline regarding
the most important
prognostic indicators
1 1 1 1 1 1 1 1 1 1 1 1 0
5 There was blinding of all
participants
0 0 0 1 0 0 1 1 0 0 0 0 0
6 There was blinding of all
therapists who
administered the
therapy
0 0 0 0 0 0 1 1 0 0 0 0 0
7 There was blinding of all
assessors who
measured at least one
key outcome
1 1 1 1 1 0 1 0 0 0 0 0 0
8 Measures of at least
one key outcome were
obtained from more
than 85% of the
participants initially
allocated to groups
1 1 1 1 1 1 0 1 1 1 1 0 0
9 All participants for
whom outcome
measures were
available, received the
treatment or control
condition as allocated
or, where this was not
the case, data for at
least one key outcome
was analysed by
‘intention to treat’
1 1 1 1 1 1 1 1 1 1 1 0 0
Continued
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to interpret. Two studies had a short follow-up of 4 and
6 weeks,32 36 which for a condition usually lasting several
months reduces the clinical implication of the results. The
difference in duration of complaints at baseline also com-
plicates comparison between studies.
Effects of interventions
Corticosteroid injection
The efﬁcacy of corticosteroid injections for treating
lateral epicondylitis was investigated in eight studies
(table 3 and ﬁgure 252). For short-term follow-up, the
heterogeneity between studies made pooling of out-
comes possible only for pain. For corticosteroid injection
versus no intervention or NSAIDs, we found strong
evidence for a beneﬁcial effect on overall improvement
and a large positive effect on pain.29 30 35 36 38 For
grip strength, we found moderate evidence for a
negative effect.35 For corticosteroid injection versus lido-
caine injection, evidence was conﬂicting for effect on
pain, with two studies showing a large positive effect
(Price et al34 using hydrocortisone and triamcinolone)
and one showing no signiﬁcant difference.31 For
maximum grip strength, the evidence was also conﬂict-
ing, with one study showing a large positive effect of
treatment (Price et al34 using triamcinolone), and
two studies showing no statistical difference
(Lindenhovius et al31, Price et al34 using hydrocortisone).
For corticosteroid injection, exercise and stretching
versus exercise and stretching alone, we found moderate
evidence for no signiﬁcant difference on pain and grip
strength.33
At intermediate follow-up, we found sufﬁcient homo-
geneity to pool estimates for overall improvement29 30 38
and pain29 30 35 38 for corticosteroid injection versus no
intervention or NSAIDs. For overall improvement, this
showed a medium negative effect and for pain, a small
negative effect. For maximum grip strength, pooling of
corticosteroid injection versus no intervention, NSAIDS
and lidocaine showed a small negative effect.31 34 35 For
corticosteroid injection versus lidocaine injection,
pooling of estimates was not possible due to heterogen-
eity. For pain, two studies showed a large negative effect
(Price et al34 using hydrocortisone and triamcinolone),
and one study showed no signiﬁcant difference;31 thus,
the evidence was conﬂicting. For grip strength, the evi-
dence was also conﬂicting, with the same two studies
showing a large negative effect34 and one showing no
signiﬁcant difference.31 For corticosteroid injection,
exercise and stretching versus exercise and stretching
alone, we found moderate evidence of no signiﬁcant
effect on pain.33
At long-term follow-up, pooled estimates of overall
improvement showed no difference in the effect of cor-
ticosteroid injection versus no intervention or
NSAIDs.29 30 35 38 For pain, heterogeneity prevented
pooling and we found the evidence conﬂicting with one
study showing a large negative effect,30 and three others
showing no signiﬁcant difference in effect.29 35 38 For
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grip strength, we found moderate evidence of no signiﬁ-
cant difference.35 For corticosteroid injection versus lido-
caine injection and corticosteroid injection, and exercise
and stretching versus exercise and stretching alone, we
found no data on the long-term effect.
Physiotherapy
We included ﬁve studies (n=600) investigating
non-electrotherapeutical physiotherapy, representing ﬁve
different treatment modalities (table 4 and ﬁgure 352).
Two studies investigated the efﬁcacy of manipulation
and exercise versus no intervention.29 38 In the short
term, the pooled estimates showed a large positive
effect on overall improvement. For pain, pooling was not
possible due to heterogeneity. We found strong evidence
for a beneﬁcial effect, whereas for pain-free grip
strength we found moderate evidence for a beneﬁcial
effect. In the intermediate term, the pooled
estimates showed no difference between treatment and
control for either pain or overall improvement. There
Table 3 Effect size of improvement rate, reduction in pain and increase in grip strength for corticosteroid injection
Short term Intermediate term Long term
4–12 weeks 26 weeks 52 weeks
Overall improvement RR (95% CI) RR>1 favours treatment
CSI vs no intervention or NSAIDs
Bisset 2.94 (1.90 to 4.45)* 0.55 (0.41 to 0.73)* 0.75 (0.62 to 0.90)*
Coombes 7.32 (2.83 to 18.94)* 0.68 (0.50 to 0.92)* 0.91 (0.77 to 1.06)
Hay 1.60 (1.18 to 2.17)* 0.77 (0.60to 0.98)* 1.07 (0.88 to 1.30)
Smidt 2.86 (1.96 to 4.16)* – 0.84 (0.68 to1.02)
Toker 2.27 (1.04 to 4.97) * – –
Pooled – 0.66 (0.53 to 0.81) * 0.87 (0.73 to 1.04)
Heterogeneity >65% p=0.21, I2=35% p=0.07, I2=58%
Pain (negative value favours treatment) SMD (95% CI)
CSI vs no intervention or NSAIDs
Bisset −1.43 (−1.83 to −1.04)* 0.40 (0.04 to 0.76)* 0.27 (−0.08 to 0.62)
Coombes −2.14 (−2.68 to −1.60)* 0.16 (−0.28 to 0.59) 0.08 (−0.35 to 0.52)
Hay −1.05 (−1.45 to−0.66)* 0.42 (0.04 to 0.80)* 1.35 (0.94 to 1.76)*
Smidt −1.49 (1.89 to−1.08)* 0.27 (−0.09 to 0.63) 0.15 (−0.20 to 0.51)
Toker −1.14 (−2.07 to −0.22)* – –
Pooled −1.43 (−1.64 to −1.23)* 0.32 (0.13 to 0.51)*
Heterogeneity p=0.032, I2=62% p=0.79, I2=0% >65%
CSI vs lidocaine injection
Lindenhovius −0.25 (−0.74 to 0.24) 0.27 (−0.30 to 0.84) –
Price 1 −1.06 (−1.63 to −0.49)* 3.13 (2.31 to 3.95)* –
Price 2 −3.37 (−4.20 to −2.54)* 1.55 (0.93 to 2.17)*
Pooled – – –
Heterogeneity >65% >65% –
All above pooled – – –
Heterogeneity >65% >65% –
CSI, exercise and stretching vs exercise and stretching
Newcomer† 0.16 (−0.49 to 0.81) −0.37 (−1.04 to 0.30) –
Maximum grip strength (positive value favours treatment) SMD (95% CI)
CSI vs no intervention or NSAIDs
Smidt −1.42 (−1.82 to −1.03)* −0.38 (−0.74 to −0.02)* −0.36 (−0.72 to 0.002)
No pooling – –
CSI vs lidocaine injection
Lindenhovius −0.19 (−0.68 to 0.30) 0.07 (−0.50 to 0.64)
Price 1 −0.06 (−0.59 to 0.48) −0.98 (−1,58 to −0.38)*
Price 2 2.31 (1.62 to 3.00)* −0.86 (−1.44 to −0.29)* –
Pooled – –
Heterogeneity >65% >65%
All above pooled – −0.48 (−0.73 to −0.24)* –
Heterogeneity >65% p=0.04, I2=64%
CSI, exercise and stretching vs exercise and stretching
Newcomer† −0.17 (−0.61 to 0.27) – –
*Statistically significant (p<0.05); Price 1: hydrocortisone versus lidocaine and change in pain-free grip strength and Price 2: triamcinolone
versus lidocaine.
†The values for Newcomer are given as change in pain.
CSI, corticosteroid injection; NSAIDS, non-steroidal anti-inflammatory drugs; RR, relative risk; SMD, standard mean difference.
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was moderate evidence for no difference in pain-free
grip strength. In the long term, the pooled estimates
again showed no difference between treatment and
control for either pain or improvement and we found
moderate evidence for no difference in pain-free grip
strength.
The efﬁcacy of exercise versus no intervention was
investigated in one study.40 We found moderate evidence
for no short-term difference in effect for outcomes on
pain and Disability of the Arm, Shoulder and Hand
(DASH) score. There were no data on the intermediate-
term or long-term effect.
For eccentric exercise and stretching versus stretching,
investigated in one study,32 we found moderate evidence
for no short-term treatment effect for outcomes on pain,
pain-free grip strength and DASH score. There were no
data on the intermediate-term or long-term effect.
The same study also investigated the efﬁcacy of con-
centric exercise and stretching versus stretching. We
found moderate evidence for no short-term treatment
effect for outcomes on pain, pain-free grip strength and
DASH score. There were no data on the intermediate-
term or long-term effect.
Eccentric exercise with stretching versus no interven-
tion was investigated in one study.41 We found moderate
evidence for a positive effect on pain and grip strength
at short-term follow-up. There were no data on efﬁcacy
at intermediate follow-up, but in the long term we found
moderate evidence of a positive effect on overall
improvement, pain and grip strength.
Figure 2 Forest plot of effect sizes for corticosteroid injection.
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DISCUSSION
Summary of main results
This review found overall evidence for a short-term bene-
ﬁcial effect of corticosteroid injection. At intermediate
follow-up, the evidence showed an overall negative effect.
For corticosteroid injection versus lidocaine injection, we
found the evidence to be conﬂicting. At long-term
follow-up, the evidence suggests no difference in effect
on overall improvement and grip strength, but the evi-
dence was conﬂicting for pain. For manipulation and
exercise versus no intervention, we found an overall
beneﬁcial effect in the short term, but there was no sig-
niﬁcant difference at intermediate-term or long-term
follow-up. The evidence on exercise versus no
intervention showed no differences at short-term
follow-up. For eccentric exercise and stretching versus
stretching alone, the evidence showed no short-term dif-
ference in effect. The same was found for concentric
exercise and stretching versus stretching. The evidence
on eccentric exercise and stretching versus no interven-
tion showed a beneﬁcial effect in the short term and long
term, while there were no data on intermediate
follow-up.
For treating lateral epicondylitis, this review showed
evidence for a short-term beneﬁt of corticosteroid injec-
tion and manipulation with exercise. Eccentric exercise
and stretching showed beneﬁcial effect both at short-
term and long-term follow-up.
Table 4 Effect sizes of treatment effects for non-electrotherapeutic physiotherapy
Short term Intermediate term Long term
4–12 weeks 26 weeks 52 weeks
Manipulation and exercise vs no intervention
Overall improvement RR (relative risk) (95% CI)—RR>1 favours treatment
Bisset 2.44 (1.54 to 3.85)* 0.94 (0.78 to 1.12) 1.04 (0.93 to 1.15)
Coombes 4.00 (1.46 to 10.94)* 1.06 (0.89 to 1.28) 1.08 (0.99 to 1.18)
Pooled 2.75 (2.09 to 3.62)* 0.99 (0.75 to 1.30) 1.05 (0.75 to 1.49)
Heterogeneity p=0.37, I2=0% p=0.33 I2=0% p=0.57 I2=0%
Pain SMD (standardised mean difference; 95% CI)—negative value favours treatment
Bisset −0.63 (−0.99 to −0.27)* −0.25 (−0.62 to 0.11) −0.38 (−0.74 to −0.03)*
Coombes −1.27 (−1.74 to −0.79)* 0.00 (−0.44 to 0.44) 0.00 (−0.44 to 0.44)
Pooled − −0.15 (−0.43 to 0.13) −0.23 (−-0.51 to 0.04)
Heterogeneity >65% p=0.39 I2=0% p=0.18 I2=45%
Pain-free grip strength ratio affected/ unaffected arm SMD (95%)
Bisset 0.76 (0.39 to 1.13)* 0.20 (−0.47 to 0.56) 0.17 (–0.18 to 0.52)
Exercise vs no intervention
DASH score (0−100, 100 most discomforts, negative value favours treatment) SMD (95% CI)
Peterson −0.03 (−0.47 to 0.40) –
Pain on maximum voluntary contraction SMD (95% CI)—negative value favours treatment
Peterson −0.30 (−0.74 to 0.14) –
Pain on maximum muscular elongation SMD (95% CI)—negative value favours treatment
Peterson −0.24 (−0.68 to 0.19) -–
Eccentric exercise and stretching vs stretching
DASH score (0−100, 100 most discomforts, negative value favours treatment) SMD (95% CI)
M-Silvestrini −0.07 (−0.46 to 0.60) –
Pain SMD (95% CI)—negative value favours treatment
M-Silvestrini −0.04 (−0.57 to 0.49) –
Pain-free grip strength affected arm SMD (95%)
M-Silvestrini −0.26 (−0.79 to 0.27) –
Concentric exercise and stretching vs stretching
DASH score (0−100, 100 most complaints, negative value favours treatment) SMD (95% CI)
M-Silvestrini 0.14 (−0.39 to 0.68) –
Pain SMD (95% CI)—negative value favours treatment
M-Silvestrini 0.41 (−0.13 to 0.95) –
Pain-free grip strength affected arm SMD (95% CI)
M-Silvestrini −0.34 (−0.88 to 0.20)
Eccentric exercise and stretching vs no intervention (sham ultrasound, elbow support) overall improvement RR (95% CI)—
RR>1 favours treatment
Selvanetti – − 23.39 (3.38 to 161.70)*
Pain on Ko scale (larger value means less pain) SMD (95% CI)
Selvanetti 4.45 (3.51 to 5.40)* −4.65 (3.68 to 5.63) *
Grip strength on Ko scale (larger value means greater strength) SMD (95% CI)
Selvanetti 3.16 (2.40 to 3.92)* −3.65 (2.82 to 4.47) *
*Statistically significant (p<0.05).
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Overall completeness and quality of the evidence
There is a paucity of well-designed studies for determin-
ing the effect of non-electrotherapeutic physiotherapy.
The conclusions on the effect of these treatments are
therefore limited. It was possible to do a comparison
and review of several individual studies for only one
treatment modality, manipulation and exercise versus no
intervention (table 4).
We included eight studies treating a total of 925
patients with corticosteroid injections in our review. The
conclusions for this treatment are more solid due to the
larger number of studies, seven of which had long-term
follow-up. Owing to differences in the type of corticos-
teroids used, treatment regimes and outcome measures
in the included studies, pooling of outcome measures
was difﬁcult. We found statistical heterogeneity for most
outcomes, and pooling was possible only for a few of the
outcomes and follow-ups. The long-term effect of cor-
ticosteroid injection showed conﬂicting results in the
included studies. The large differences across studies in
the duration of complaints at baseline, corticosteroids
used in different dosages and control group treatments
may explain this.
The difference in the duration of complaints at base-
line complicates the interpretation and comparison of
the results, since there might be different effects of the
treatments on an epicondylitis of recent onset compared
with one that has lasted several months. This is also
reﬂected by Cook and Purdam53 who considered tendi-
nopathy as a continuum with three stages and different
characteristics and presumably treatments for each stage.
Haahr and Andersen54 found that high physical strain at
work, work with manual tasks, high perceived stress at
baseline and a high level of pain and dysfunction seem
to predict an unfavourable outcome after 1 year. Thus,
any differences in baseline characteristics for these para-
meters might possibly inﬂuence between-group differ-
ences of outcome.
Figure 3 Forest plot of effect sizes for non-electrotherapeutic physiotherapy.
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Potential biases in the review process
The search process, selection of search terms and pos-
sible errors in reading and assessing the large number
of articles represent a possible bias. Although we have
searched several databases with a number of search
terms, we may have missed some published studies. To
reduce the risk of bias in the inclusion process, we
used two reviewers who independently screened the
articles.
Our choice of inclusion criteria, especially the type of
control or comparison treatment and the use of a cut-off
quality score (PEDro), has important implications for
the conclusions that can be drawn from this review. The
efﬁcacy of the treatments are here compared only with a
Figure 3 (Continued)
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control (no treatment) or to an underlying treatment
that is common to both intervention groups, so no con-
clusion can be drawn as to which of the two different
treatments is better.
To address the issue of publication bias, we searched
two clinical trial registries: ClinicalTrial.gov (US National
Institutes of Health) and Current Clinical Trials. We
found no completed, unpublished studies on corticoster-
oid injection. Two completed studies on
non-electrotherapeutic physiotherapy were found, one
from the UK completed in 2008 on manipulation with
movement and one from Sweden completed in 2009 on
eccentric training. We have found no published articles
from these studies. Unpublished studies are not indexed
in PubMed or other databases, and older studies may
have been conducted without registration in a clinical
trial registry, making it difﬁcult to make an overall assess-
ment of publication bias.
Agreements and disagreements with other reviews
Our ﬁndings agree with earlier reviews.14 16 17 55 We
found consistent evidence of a beneﬁcial short-term
effect of corticosteroid injections, but evidence on the
long-term effect is still conﬂicting. Coombes et al15
found in their review that corticosteroid injections have
a worse outcome in the long term than most conserva-
tive interventions for tendinopathies of different loca-
tions. The included studies in our review did not allow
for a similar strong conclusion on the long-term effect
of corticosteroid injections. For non-electrotherapeutical
physiotherapy, we agree with earlier reviews14 16 18 19 21
that there is moderate evidence of a short-term effect of
manipulation and exercise. Our review strengthens this
conclusion with the inclusion of a recently published
study.40 In addition, we found moderate evidence of the
short-term and long-term beneﬁcial effects of eccentric
exercise and stretching.
AUTHORS’ CONCLUSIONS
Implications for practice
We found that corticosteroid injection and manipulation
with exercise gave a short-term beneﬁt compared with
control for treating lateral epicondylitis. In the inter-
mediate term, treatment with corticosteroid injection
came out worse, while manipulation with exercise was
not different from control. In the long term, both treat-
ments showed no beneﬁt over control. For patients
wanting treatment, it seems reasonable to recommend
manipulation and exercise. For patients with mild symp-
toms, a wait-and-see approach would be appropriate.
Though showing a large short-term beneﬁt, the negative
intermediate-term effect and uncertain long-term effect
of corticosteroid injection make this treatment difﬁcult
to recommend. Eccentric exercise with stretching
showed efﬁcacy both at short-term and long-term
follow-up, but only in one study.
Implications for research
We found few studies and some conﬂicting results on
the long-term efﬁcacy of corticosteroid injection. More
trials or a meta-analysis with individual patient data from
earlier studies might give better answers to the question
on the long-term effect.
For non-electrotherapeutical physiotherapy, more
studies with a randomised controlled design are needed.
Blinding, for example by using a blinded assessor,
should be applied wherever possible. The promising
results of manipulation with exercise and eccentric exer-
cise with stretching need further investigation.
Future studies should differentiate between acute and
chronic complaints. Baseline levels of perceived pain,
stress levels, handedness and presence of physical stress
at work should be recorded. Standardisation in the
usage of outcome measures will enable data pooling and
meta-analyses in future reviews. Studies investigating the
combined effect of physiotherapy and corticosteroid
injection treatments would also be useful. Most patients
with acute lateral epicondylitis are treated in a general
practice setting, and future research should be per-
formed in such a setting.
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